DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ezziddin S. et al.
Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.
Eur J Nucl Med Mol Imaging 2014;
41: 925-933
We do not assume any responsibility for the contents of the web pages of other providers.